Wechselwirkungen · Hizentra
Hizentra 200 mg/ml solution for subcutaneous injection Hizentra 200 mg/ml solution for subcutaneous injection in pre-filled syringe · Abschnitt 4.5 · PDF-Seite 7
HOS-124345 · Präparat HOS-095847
Live attenuated virus vaccines Immunoglobulin administration may impair for a period of at least 6 weeks and up to 3 months the efficacy of live attenuated virus vaccines such as measles, rubella, mumps and varicella. After administration of this medicinal product, an interval of 3 months should elapse before vaccination with live attenuated virus vaccines. In the case of measles, this impairment may persist for up to 1 year. Therefore patients receiving measles vaccine should have their antibody status checked.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-09-26T15:00:00Z · SHA-256 6e3ba103d45191869d80ec276db5e71b5f2ce30d8df7255e410a1ec3d7a7232d · Passage 798f54199c64fe2df4cee37a35a7ef0eff9265d34e770980f671607675841b5a · Zeichen 0–517 im Abschnitt